Fulcrum Therapeutics maintains a lean, specialized workforce of scientific researchers, clinical operations personnel, and corporate administrative staff numbering roughly 50 to 80 employees. As a clinical-stage biopharmaceutical firm headquartered in Cambridge, Massachusetts, its personnel count fluctuates periodically in response to strategic reorganizations, pipeline prioritization shifts, and corporate restructurings aimed at optimizing operational efficiency and preserving capital reserves for ongoing drug development programs.